
Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 12, 2021, titled "Strides receives USFDA approval for Prednisone Tablets".
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange regarding a press release dated February 12, 2021, titled "Strides receives USFDA approval for Prednisone Tablets".
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science